Tech Company Financing Transactions
IntegenX Funding Round
IntegenX closed a $10 million venture capital round on 9/24/2014. Backers included Horizon Technology Finance.
Transaction Overview
Company Name
Announced On
9/24/2014
Transaction Type
Debt
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
IntegenX will use the funds primarily for working capital purposes.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5720 Stoneridge Dr. 300
Pleasanton, CA 94588
USA
Pleasanton, CA 94588
USA
Phone
Website
Email Address
Overview
Rapid DNA for Human Identification, Rapid NGS Library Preparation, and Nucleic Acid Stabilization. IntegenX Corporate Information, Events, and Product News.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Schueren
Chief Operating Officer
David Smith
VP - Product Management
David King
VP - Sales
Jay Therrien
Browse more venture capital transactions:
Prev: 9/24/2014: Udacity venture capital transaction
Next: 9/24/2014: Performance Horizon venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs